These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis. Kim JH, Yoon HK, Kim SY, Kim KM, Ko GY, Gwon DI, Sung KB. Aliment Pharmacol Ther; 2009 Jun 15; 29(12):1291-8. PubMed ID: 19392861 [Abstract] [Full Text] [Related]
23. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts. Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C. Cardiovasc Intervent Radiol; 2006 Jun 15; 29(5):778-84. PubMed ID: 16779690 [Abstract] [Full Text] [Related]
24. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization. Nishihara Y, Aishima S, Kuroda Y, Iguchi T, Taguchi K, Asayama Y, Taketomi A, Kinukawa N, Honda H, Tsuneyoshi M. J Gastroenterol Hepatol; 2008 Dec 15; 23(12):1860-8. PubMed ID: 18823434 [Abstract] [Full Text] [Related]
25. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Yang P, Liang M, Zhang Y, Shen B. Adv Ther; 2008 Aug 15; 25(8):787-94. PubMed ID: 18670743 [Abstract] [Full Text] [Related]
27. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Nakashima Y, Ikeno H, Orito N, Notsumata K, Watanabe H, Toya D, Tanaka N, Matsui O. Cardiovasc Intervent Radiol; 2010 Dec 15; 33(6):1168-79. PubMed ID: 20058008 [Abstract] [Full Text] [Related]
28. Chemoembolization in colorectal liver metastases: the rebirth. Fiorentini G, Aliberti C, Mulazzani L, Coschiera P, Catalano V, Rossi D, Giordani P, Ricci S. Anticancer Res; 2014 Feb 15; 34(2):575-84. PubMed ID: 24510986 [Abstract] [Full Text] [Related]
29. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome. Schuster R, Lindner M, Wacker F, Krössin M, Bechrakis N, Foerster MH, Thiel E, Keilholz U, Schmittel A. Melanoma Res; 2010 Jun 15; 20(3):191-6. PubMed ID: 20335820 [Abstract] [Full Text] [Related]
31. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma. Bayraktar Y, Balkanci F, Kayhan B, Uzunalimoglu B, Gokoz A, Ozisik Y, Gurakar A, Van Thiel DH, Firat D. Hepatogastroenterology; 1996 Jun 15; 43(9):681-7. PubMed ID: 8799415 [Abstract] [Full Text] [Related]
33. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection. Shim JH, Kim KM, Lee YJ, Ko GY, Yoon HK, Sung KB, Park KM, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Ann Surg Oncol; 2010 Mar 15; 17(3):869-77. PubMed ID: 20033326 [Abstract] [Full Text] [Related]
34. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma]. Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC. Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104 [Abstract] [Full Text] [Related]
35. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N. J Hepatobiliary Pancreat Surg; 2006 Mar 24; 13(6):537-42. PubMed ID: 17139428 [Abstract] [Full Text] [Related]